Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Polygiene Group AB (POLYG.ST)
Malmö, SE
Based in Malmö, Sweden, and founded in 2005, Polygiene Group AB develops, produces, and markets advanced solutions designed to control odors and maintain freshness across a wide range of materials. These applications extend to clothing, athletic equipment, various textiles, and other products. The company's operations span globally, serving markets throughout the Middle East, Africa, the Asia Pacific region, the Americas, and Europe. Polygiene caters to a diverse portfolio of partners across sectors including sports and outdoor activities, fashion and lifestyle, industrial uses, workwear, hospitality, household items, pet care, healthcare, water management, and paper and packaging. Its entire product line is offered under the Polygiene brand. The company officially changed its name to Polygiene Group AB in June 2022, having previously operated as Polygiene AB (publ.).
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.36% | -3.00% | -26.33% | -12.35% | -40.61% | -36.88% | -55.23% | -0.17% | -83.23% | -55.57% | -53.63% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-6.6% Q1'26: -27.0% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-215.4% Q1'26: +93.0% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-4.3% Q1'26: +14.4% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+0.3% Q1'26: -1.7% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+0.2% Q1'26: -0.9% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-2.3% ★ Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.77× ★ Q1'26: 0.78× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
61.56M
est: 58.85M (+4.6%)
|
75.68M
est: 78.94M (-4.1%)
|
69.04M
est: 71.70M (-3.7%)
|
68.80M
est: 68.00M (+1.2%)
|
83.93M
est: 85.62M (-2.0%)
|
181.61M
est: 198.75M (-8.6%)
|
173.56M
est: 179.00M (-3.0%)
|
113.54M
est: 118.00M (-3.8%)
|
156.95M
est: 152.70M (+2.8%)
|
146.65M
est: 154.10M (-4.8%)
|
168.80M
168.80M – 168.80M
+9.5% YoY
|
201.60M
201.60M – 201.60M
+19.4% YoY
|
221.80M
221.80M – 221.80M
+10.0% YoY
|
| EBITDA |
—
est: -6.12M (+100.0%)
|
-5.91M
est: -8.20M (+27.9%)
|
-2.01M
est: -7.45M (+73.1%)
|
-5.38M
est: -7.07M (+23.9%)
|
701.0K
est: -8.90M (+107.9%)
|
43.99M
est: -20.66M (+313.0%)
|
19.10M
est: -18.60M (+202.7%)
|
-305.61M
est: -12.26M (-2,392.1%)
|
18.80M
est: -14.88M (+226.3%)
|
5.97M
est: -15.02M (+139.7%)
|
-16.45M
-16.45M – -16.45M
-9.5% YoY
|
-19.65M
-19.65M – -19.65M
-19.4% YoY
|
-21.62M
-21.62M – -21.62M
-10.0% YoY
|
| EBIT |
-3.39M
est: -7.22M (+53.0%)
|
-6.10M
est: -9.68M (+37.0%)
|
-2.81M
est: -8.79M (+68.1%)
|
-6.57M
est: -8.34M (+21.2%)
|
-1.05M
est: -10.50M (+90.0%)
|
40.86M
est: -24.37M (+267.7%)
|
15.99M
est: -21.95M (+172.9%)
|
-309.40M
est: -14.47M (-2,038.6%)
|
12.93M
est: -18.26M (+170.8%)
|
362.0K
est: -18.43M (+102.0%)
|
-20.19M
-20.19M – -20.19M
-9.5% YoY
|
-24.11M
-24.11M – -24.11M
-19.4% YoY
|
-26.53M
-26.53M – -26.53M
-10.0% YoY
|
| Net Income |
-3.16M
est: -3.54M (+10.6%)
|
-5.41M
est: -10.73M (+49.6%)
|
5.91M
est: -2.82M (+309.4%)
|
-5.17M
est: -9.35M (+44.7%)
|
-1.74M
est: 5.07M (-134.3%)
|
32.83M
est: 49.32M (-33.4%)
|
8.36M
est: 37.02M (-77.4%)
|
-321.95M
est: 12.71M (-2,632.4%)
|
16.83M
est: 10.96M (+53.6%)
|
-5.58M
est: 5.11M (-209.1%)
|
25.93M
25.93M – 25.93M
+407.1% YoY
|
35.43M
35.43M – 35.43M
+36.6% YoY
|
—
— – —
-100.0% YoY
|
| SGA |
38.82M
est: 27.84M (+39.4%)
|
30.59M
est: 37.34M (-18.1%)
|
35.08M
est: 33.92M (+3.4%)
|
53.09M
est: 32.17M (+65.0%)
|
51.55M
est: 40.50M (+27.3%)
|
74.23M
est: 94.02M (-21.0%)
|
55.20M
est: 84.68M (-34.8%)
|
54.74M
est: 55.82M (-1.9%)
|
85.10M
est: 63.47M (+34.1%)
|
47.96M
est: 64.05M (-25.1%)
|
70.16M
70.16M – 70.16M
+9.5% YoY
|
83.79M
83.79M – 83.79M
+19.4% YoY
|
92.19M
92.19M – 92.19M
+10.0% YoY
|
| EPS |
-0.16
est: -0.09 (-69.0%)
|
-0.26
est: -0.29 (+9.4%)
|
0.29
est: -0.08 (+484.5%)
|
-0.25
est: -0.25 (+0.0%)
|
-0.08
est: 0.14 (-162.4%)
|
0.92
est: 1.32 (-30.3%)
|
0.23
est: 0.99 (-76.8%)
|
-8.31
est: 0.34 (-2,544.1%)
|
0.13
est: 0.30 (-56.7%)
|
-0.15
est: 0.14 (-207.1%)
|
0.71
0.71 – 0.71
+407.1% YoY
|
0.97
0.97 – 0.97
+36.6% YoY
|
—
— – —
-100.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-28 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-27 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-26 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-25 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-22 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-21 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-20 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-19 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-18 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-15 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-12 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-11 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-08 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-07 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-06 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-05 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-04 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-30 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-29 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-28 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-27 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-23 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-22 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-21 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Ulrika Bjork | Executive Officer | 4M | female |
| Sandrine Garnier | Chief Executive Officer | 3M | — |
| Daniel Röme | Chief Technology Innovation Officer | 125.0K | male |
| Kristina Kruhsberg | Press Officer | — | female |
| Lesley Taylor | Chief Regulatory Officer | — | female |
| Matt Fisher | Chief Operating Officer | — | male |
| Niklas Blomstedt | CFO & Deputy CEO | — | male |
| Paul Willocks | Global Marketing Director | — | — |
| Peter Sjösten | Vice President Commercial Operations APAC | — | male |
| India Hanspal | Global Commercial Head of Product Protection | — | — |
| Haymo Strubel | Vice President of Commercial Operations EMEA | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for POLYG.ST
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
